- Home
- ATTO vs INMD Comparison
ATTO vs INMD Comparison
Compare ATTO & INMD Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
Company Overview
Basic Information| Metric | ATTO | INMD |
|---|---|---|
| Founded | N/A | 2008 |
| Country | United States | Israel |
| Employees | N/A | N/A |
| Industry | Biotechnology: Biological Products (No Diagnostic Substances) | Biotechnology: Electromedical & Electrotherapeutic Apparatus |
| Sector | Health Care | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 1.0B | 857.4M |
| IPO Year | 2026 | 2018 |
Fundamental Metrics
Financial Performance| Metric | ATTO | INMD |
|---|---|---|
| Price | $17.70 | $14.21 |
| Analyst Decision | | Hold |
| Analyst Count | 0 | 5 |
| Target Price | N/A | ★ $17.33 |
| AVG Volume (30 Days) | 264.4K | ★ 449.7K |
| Earning Date | N/A | 05-06-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | N/A | N/A |
| EPS | N/A | ★ N/A |
| Revenue | N/A | N/A |
| Revenue This Year | N/A | $1.74 |
| Revenue Next Year | N/A | $3.26 |
| P/E Ratio | ★ N/A | $10.11 |
| Revenue Growth | N/A | N/A |
| 52 Week Low | $16.15 | $12.72 |
| 52 Week High | $28.00 | $16.74 |
Technical Indicators
Market Signals| Indicator | ATTO | INMD |
|---|---|---|
| Relative Strength Index (RSI) | 34.80 | 31.72 |
| Support Level | $16.15 | $13.27 |
| Resistance Level | $24.89 | $15.24 |
| Average True Range (ATR) | 2.07 | 0.19 |
| MACD | -0.70 | -0.04 |
| Stochastic Oscillator | 9.50 | 4.29 |
Price Performance
Historical ComparisonAbout ATTO Attovia Therapeutics Inc. Common Stock
Attovia Therapeutics Inc is a clinical stage biotechnology company focused on research and development of therapeutic products in the fields of immune-mediated diseases. Its product pipeline includes ATTO-1310 and ATTO-2306 for immune-dermatology indications and ATTO-1091 for inflammatory diseases, including inflammatory bowel disease (IBD). The company's product candidates are developed using its ATTOBODY biologics platform.
About INMD InMode Ltd.
InMode Ltd provides minimally and non-invasive surgical aesthetic and medical treatment solutions. Its products and solutions address three energy-based treatment categories that include face & body contouring, medical aesthetics, and women's health. InMode has developed products using its technology for plastic surgery, dermatology, gynecology, and ophthalmology. Its product platforms include BodyTite, Optimas, Votiva, Contoura, Triton, EmbraceRF, EvolveX, Evoke, EmpowerRF, and Morpheus8, among others. Geographically, the company generates the majority of its revenue from the United States, followed by Europe, Asia, Israel, and other regions.